Clinical spectrum and treatment response in patient of chronic myeloid leukemia in correlation with ABO blood group

BACKGROUND: Several studies have been conducted to evaluate and investigate the molecular mechanisms underlying alterations in ABO blood group antigens in oncogenesis. We observed that no study has been reported yet that correlate cytological, molecular and haematological responses of Imatinib thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Meher, Mukti P., Gupta, Saumya, Singh, Arun Kumar, Kumar, Prabhat, Kumar, Sandeep, Amrit, Amar Kumar, Arora, Disha, Bharti, Anju, Kumar, Sandip, Meena, Lalit Prashant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648264/
https://www.ncbi.nlm.nih.gov/pubmed/36387650
http://dx.doi.org/10.4103/jfmpc.jfmpc_2167_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648264/
https://www.ncbi.nlm.nih.gov/pubmed/36387650
http://dx.doi.org/10.4103/jfmpc.jfmpc_2167_21

Ejemplares similares